Related Experiment Videos
Adhesion molecules as targets for cancer therapy
Y W Huang1, R Baluna, E S Vitetta
1Cancer Immunobiology Center, University of Texas Southwestern Medical Center, Dallas 75235-8576, USA.
Histology and Histopathology
|April 1, 1997
Summary
Adhesion molecules are crucial in cancer progression and metastasis. Targeting these molecules, through strategies like monoclonal antibodies, offers promising therapeutic approaches to inhibit tumor growth and spread.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- Adhesion molecules regulate cell-cell and cell-matrix interactions, vital for physiological and pathological processes.
- Emerging evidence implicates adhesion molecules in tumor progression, growth, and metastasis, with some acting as tumor suppressors.
Purpose of the Study:
- To review current understanding of adhesion molecules' roles in cancer pathogenesis.
- To explore therapeutic strategies targeting adhesion molecules for cancer treatment.
Main Methods:
- Review of existing scientific literature and research findings.
- Analysis of therapeutic strategies including monoclonal antibodies, peptide analogues, soluble adhesion molecules, antisense oligonucleotides, and gene therapy.
Main Results:
- Adhesion molecules significantly influence tumor growth and organ-specific metastasis.
- Inhibiting tumor cell interactions via anti-adhesion strategies can suppress tumor progression.
- Various anti-adhesion therapies have shown efficacy in preclinical cancer models.
Conclusions:
- Adhesion molecules represent key targets for novel cancer therapies.
- Therapeutic strategies aimed at modulating adhesion molecule function hold potential for inhibiting tumor growth and metastasis.
- Restoring tumor-suppressive adhesion molecule functions via gene therapy is a viable approach.